Status:
COMPLETED
Systematic Screening for Risk-factors for Ulcer Bleeding Before Anti-thrombotic Treatment
Lead Sponsor:
Odense University Hospital
Collaborating Sponsors:
Aarhus University Hospital
Danish Heart Foundation
Conditions:
Coronary Occlusion/Thrombosis
Peptic Ulcer Hemorrhage
Eligibility:
All Genders
Phase:
NA
Brief Summary
In a prospective randomised study design to investigate, if a systematic risk factor screening for bleeding ulcer in patients, who following percutaneous coronary intervention (PCI) commence a one yea...
Eligibility Criteria
Inclusion
- Patients who has had a PCI with stenting or balloon dilatation in the cardiology department at Odense University Hospital, Århus University Hospital and Ålborg Sygehus, where subsequent treatment with low-dose aspiring and clopidogrel or another thienopyridine is planned for one year.
Exclusion
- previous PCI with stenting or balloon dilatation
- treatment with clopidogrel prior to PCI
- lack of informed consent
Key Trial Info
Start Date :
April 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
2024 Patients enrolled
Trial Details
Trial ID
NCT01447498
Start Date
April 1 2011
End Date
May 1 2014
Last Update
November 11 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Odense University Hospital
Odense, Denmark, 5000